LAMZEDE subst sèche 10 mg flac
7680685910011
CH-68591
A16AB15
07.14.0.
1 / 3
google
Details
- Product number
- 6859101
- CPT
- -
- Packaging group
- 1
- Unit
- Ampulle(n)
- Composition
- velmanasum alfa 10 mg, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, mannitolum, glycinum, pro vitro corresp. natrium 0.817 mg.
Articles (1)
Lamzede 10 mg, poudre pour solution pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.817 MG | Substance | HBESI |
Authorization holder
Chiesi SA
1752 Villars-sur-Glâne
Authorization information
- Swissmedic authorization number
- 68591
- Drug name
- Lamzede, poudre pour solution pour perfusion
- Galenic form
- PULVI
- ATC Code
- A16AB15
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/08/2022
- Authorization expiration date
- 25/08/2029
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LAMZEDE subst sèche 10 mg flac
- Description (DE)
- LAMZEDE Trockensub 10 mg Durchstf
- Market launch
- 26/08/2022
- Narcotic (BTM)
- No